Google
ZYBT Stock Price & Analysis — Zhengye Biotechnology Holding Limited Ordinary Shares (Healthcare >> Drug Manufacturers - Specialty & Generic)
ZYBT FAQ
What is ZYBT's ROE?
Zhengye Biotechnology Holding Limited Ordinary Shares reports a Return on Equity (ROE) of -28.53%.
What is ZYBT's dividend yield?
Zhengye Biotechnology Holding Limited Ordinary Shares offers a dividend yield of 0.00%.
What is ZYBT's Quality Score?
Our AI rates ZYBT's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ZYBT?
Our AI Timing Score for ZYBT is 71 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ZYBT belong to?
Zhengye Biotechnology Holding Limited Ordinary Shares is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange
ZYBT AI Analysis Summary
Our AI summary for ZYBT: Zhengye Biotechnology Holding Limited Ordinary Shares (NASDAQ), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 0.00, ROE of -28.53%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 71/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 1.28
Price
-0.05
(-3.76%)
Day Change
|
|
|---|
ZYBT, the overall quality is not good ( Quality = 23) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...
| Quality Factors |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.28 |
| PBV / Sector |
0.21 / 10.04
GREAT
|
| Earning Per Share | -1.45 |
| PE / Sector |
N/A / 32.60
|
| PEG or PE/Growth / Sector |
N/A / -0.13
|
| Average 1M Daily Value |
61.73 M
|
| Average 1W Daily Value |
0.26 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
47% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-08-05 08:01:08 |
| Symbol | ZYBT |
| Name | ZHENGYE BIOTECHNOLOGY HOLDING LIMITED ORDINARY SHARES |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 47.39 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 63.03 / 10,527.15 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: No.1 Lianmeng Road, Jilin, China
Phone: 86 432 6304 7008
Website: https://www.jlzybio.com
Employees: 269
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
Top Related Stocks
Stocks in the Same Sector
Healthcare › Drug Manufacturers - Specialty & GenericAnalysed on the same criteria, ordered by market cap